Viva Gel - Wikipedia, the free encyclopedia
The NIH and NIAID have awarded grants totaling $25.7 million for VivaGel's continued development and testing. Experimental results to date indicate an approximate 85-100 ...
Mercier (cycling team) - Wikipedia, the free encyclopedia
From 1977 until 1982, Miko were the main sponsor making the Miko-Mercier-Vivagel team and for the final two years of the team, 1982 and 1983, COOP was the other sponsor making COOP ...
FDA Warning for N-9 - an Opportunity for VivaGel(R)
MELBOURNE, Australia, Dec. 21 /PRNewswire-FirstCall/ -- Starpharma Holdings Limited (ASX:SPL, OTC: SPHRY), developer of VivaGel(R) vaginal microbicide today welcomed a decision by ...
Starpharma Holdings Limited Announce New VivaGel(R) Clinical Trial ...
Starpharma Holdings Limited (ASX:SPL)(PINK:SPHRY) announced the start of its next clinical trial of VivaGel(R). The study will measure the level of antiviral activity retained by ...
AIDSinfo - HIV/AIDS Drug Information - SPL7013
Brand Name: VivaGel : Drug Class: Microbicides: Drug Description: SPL7013 is a lysine-based dendrimer with naphthalene disulfonic acid surface groups. It is the active ingredient ...
Starpharma's VivaGelR patent approved in Japan
This approval means that VivaGel and the VivaGel coated condom are now covered by granted patents in all major markets including Europe, the US and Japan. Last month Starpharma ...
Retention and Duration of Activity of SPL7013 (VivaGel®) After ...
Sponsors and Collaborators: Starpharma Pty Ltd National Institute of Allergy and Infectious Diseases (NIAID) Information provided by: Starpharma Pty Ltd
Mercier (cycling team) - Wikipedia, the free encyclopedia
From 1977 until 1982, Miko were the main sponsor making the Miko-Mercier-Vivagel team and for the final two years of the team, 1982 and 1983, COOP was the other sponsor making COOP ...
Starpharma announces VivaGel to be used as a condom coating
Starpharma Holdings Limited today announced that it has signed an agreement with a leading condom company in relation to the use of VivaGel as a condom coating.
VivaGel New Clinical Trial Commences
Starpharma Holdings Limited today announced the start of its next clinical trial of VivaGel®. The study will measure the level of antiviral activity retained by VivaGel® after ...
